Elan enters $1B royalty deal with Theravance
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.
Medications
May 13, 2013 |
not rated yet |
0
Combination therapy provides similar clinical benefit as single drug treatment in MS
People with multiple sclerosis (MS) who were treated with combination therapy did not see significant clinical benefit over those treated with single drug therapy, but combination therapy did reduce the development of new ...
Neuroscience
Mar 11, 2013 |
not rated yet |
0
Common MS drugs taken together do not reduce relapse risk
A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While ...
Neuroscience
Mar 11, 2013 |
not rated yet |
0
Moxifloxacin monotherapy equivalent to antibiotic combo
(HealthDay)—Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer ...
Cancer
Jan 30, 2013 |
not rated yet |
0
Type 2 diabetes tablet promotes weight loss
(Medical Xpress)—A new drug for type 2 diabetes, involving research at Aston University is being launched as a once-daily tablet for adults with the condition.
Overweight and Obesity
Dec 06, 2012 |
4 / 5 (1) |
0
Pulmonary hypertension combination therapy may lead to greater disease burden
Patients with pulmonary arterial hypertension (PAH) receiving combination therapy with intravenous (IV) PGI2 may suffer from greater disease burden compared with those receiving monotherapy or combination therapy, excluding ...
Diseases, Conditions, Syndromes
Oct 22, 2012 |
not rated yet |
0
Added benefit of eribulin in breast cancer is not proven
Eribulin (trade name: Halaven) was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy.
Cancer
Aug 16, 2012 |
not rated yet |
0
Corticosteroids not effective for treating acute sinusitis
Corticosteroids, frequently prescribed to alleviate acute sinusitis, show no clinical benefit in treating the condition, according to a randomized controlled trial published in CMAJ (Canadian Medical Association Journal). ...
Diseases, Conditions, Syndromes
Aug 07, 2012 |
not rated yet |
0
Intravesical chondroitin sulfate of little benefit in cystitis
(HealthDay) -- Intravesical sodium chondroitin sulfate is not recommended for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) in women as it produces only minor improvements in symptoms ...
Diseases, Conditions, Syndromes
Jun 06, 2012 |
not rated yet |
0
Tocilizumab is more effective than adalimumab at reducing signs and symptoms of rheumatoid arthritis
Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than adalimumab monotherapy in the treatment of rheumatoid arthritis ...
Arthritis & Rheumatism
Jun 06, 2012 |
5 / 5 (1) |
0
Artemisinin-resistant untreatable malaria increasing rapidly along the Thailand-Myanmar border: study
Evidence that the most deadly species of malaria parasite, Plasmodium falciparum, is becoming resistant to the front line treatment for malaria on the border of Thailand and Myanmar (Burma) is reported in The ...
Diseases, Conditions, Syndromes
Apr 05, 2012 |
5 / 5 (2) |
0
|
Grafting of human spinal stem cells into ALS rats best with immunosuppressant combination
A team of researchers grafting human spinal stem cells into rats modeled with amyotrophic lateral sclerosis (ALS), also known as "Lou Gehrig's Disease," a degenerative, lethal, neuromuscular disease, have tested four different ...
Medical research
Dec 19, 2011 |
not rated yet |
0
A more ethical way to compare epilepsy treatments
For the first time, a new research methodology recently approved by the Food and Drug Administration has been used to demonstrate that converting patients from one anti-epileptic drug to another - in this case, lamotrigine ...
Neuroscience
Dec 05, 2011 |
not rated yet |
0
New medication increases HDL cholesterol and decreases LDL cholesterol levels
Among patients with sub-optimal low-density lipoprotein cholesterol (LDL-C) or high-density lipoprotein cholesterol (HDL-C) levels, use of the drug evacetrapib alone or in combination with statin medications was associated ...
Medications
Nov 15, 2011 |
not rated yet |
0
Vascular risk linked to long-term antiepileptic drug therapy
New research reveals that patients with epilepsy who were treated for extended periods with older generation antiepileptic drugs (AEDs) may be at increased risk for developing atherosclerosis, a common disorder known as hardening ...
Cardiology
Nov 15, 2011 |
not rated yet |
0
- Pages: 1
